A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study

Diabetes, Obesity and Metabolism - United Kingdom

doi 10.1111/dom.13473